K. Lee Blalack II


Thank you for your interest. Before you communicate with one of our attorneys, please note: Any comments our attorneys share with you are general information and not legal advice. No attorney-client relationship will exist between you or your business and O’Melveny or any of its attorneys unless conflicts have been cleared, our management has given its approval, and an engagement letter has been signed. Meanwhile, you agree: we have no duty to advise you or provide you with legal assistance; you will not divulge any confidences or send any confidential or sensitive information to our attorneys (we are not in a position to keep it confidential and might be required to convey it to our clients); and, you may not use this contact to attempt to disqualify O’Melveny from representing other clients adverse to you or your business. By clicking "accept" you acknowledge receipt and agree to all of the terms of this paragraph and our Disclaimer.


Lee Blalack is O’Melveny’s regional head of litigation for Washington, DC. He is an accomplished commercial litigator and trial lawyer who, during more than two decades of practice, has secured favorable bench and jury verdicts in both civil and criminal trials. He represents targets of grand jury, congressional, and regulatory investigations, and frequently conducts internal corporate investigations. Year after year, Washingtonian magazine has named Lee one of the city’s “Top Lawyers,” and, in 2007, The American Lawyer magazine selected Lee as one of the top 50 litigators in the country in its “Fab Fifty” survey.

He has represented such notable corporate clients as Humana, FedEx Ground Package Systems, Ford Motor Company, UBS AG, UnitedHealth Group, and Goldman Sachs. Lee has also been engaged by nonprofit organizations such as Harvard University, the Brookings Institution, the US Chamber of Commerce, America’s Health Insurance Plans, and The Museum of Modern Art to defend the organizations in government investigations and civil litigation. And he has represented prominent public officials in connection with government and ethics investigations, including members of Congress and cabinet secretaries. Lee currently serves on the Firm’s Policy Committee, which is the Firm’s board of directors, and has previously served on the Firm’s Partner Admissions Committee.


Honors & Awards

  • Recommended by Legal 500 for Healthcare


Bar Admissions

  • District of Columbia

Court Admission

  • US Court of Federal Claims
  • US District Court, District of Columbia
  • US Tax Court


  • University of Memphis, J.D., 1994: magna cum laude; articles editor, University of Memphis Law Review
  • University of Memphis, MA, 1996
  • University of Memphis, BA, 1990

Professional Activities


  • Honorable Harry W. Wellford, US Court of Appeals, Sixth Circuit


  • American Bar Association
  • District of Columbia Bar Association
  • Maryland Bar Association
  • Tennessee Bar Association 


  • “Preparing for Aggressive Congressional Investigations in 2013,” Corporate Counsel, co-authored with David Leviss and Zachary Kaufman (June 6, 2012)
  • “Corporate America, Beware: GOP Won’t End Scrutiny,” Roll Call (February 3, 2003)
  • “In the Line of Fire: Congressional Hearings Play By Their Own Rules,” Legal Times (September 21, 1998)
  • Former Senate Majority Leader William H. Frist, M.D., in connection with investigations surrounding his sale of stock from federally qualified blind trusts
  • Former Senator Pete Domenici in connection with a federal grand jury and Senate Ethics Committee investigation of his communications with the US Attorney for the District of New Mexico
  • Former Secretary of Commerce John Bryson in connection with a congressional investigation of government loan programs to expand broadband networks to rural areas
  • FedEx Ground Package Systems, Inc., in a three-week jury trial in federal court filed by dozens of former pickup and delivery contractors challenging their employment status
  • Humana Inc., in connection with the multi-district RICO class action suits brought by 600,000 medical doctors against the managed-care industry